These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11836028)

  • 1. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay.
    Scalone A; De Luna R; Oliva G; Baldi L; Satta G; Vesco G; Mignone W; Turilli C; Mondesire RR; Simpson D; Donoghue AR; Frank GR; Gradoni L
    Vet Parasitol; 2002 Apr; 104(4):275-85. PubMed ID: 11836028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs.
    Mettler M; Grimm F; Capelli G; Camp H; Deplazes P
    J Clin Microbiol; 2005 Nov; 43(11):5515-9. PubMed ID: 16272479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant K28 antigen in ELISA in the diagnosis of canine visceral leishmaniosis.
    Venturin GL; Bragato JP; Silva KL; de Lima VM
    Parasite Immunol; 2015 Dec; 37(12):670-3. PubMed ID: 26408410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the serological evaluation of dogs clinically suspect for canine leishmaniasis.
    Santarém N; Sousa S; Amorim CG; de Carvalho NL; de Carvalho HL; Felgueiras Ó; Brito M; da Silva AC
    Sci Rep; 2020 Feb; 10(1):3099. PubMed ID: 32080327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of immunodiagnostic tests to differentiate between dogs naturally infected with Leishmania infantum and Leishmune(®)-vaccinated dogs.
    Ribeiro RA; Teixeira-Neto RG; Belo VS; Ferreira EC; Schallig HD; Silva ES
    Vet Res Commun; 2015 Jun; 39(2):87-95. PubMed ID: 25874857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of three recombinant proteins for the development of ELISA and immunochromatographic tests for visceral leishmaniasis serodiagnosis.
    Santos ARRD; Serufo ÂV; Figueiredo MM; Godoi LC; Vitório JG; Marcelino AP; Avelar DM; Rodrigues FTG; Machado-Coelho GLL; Medeiros FAC; Jerônimo SMB; Oliveira EJ; Nascimento FC; Teixeira SMR; Gazzinelli RT; Nagem RAP; Fernandes AP
    Mem Inst Oswaldo Cruz; 2019 Feb; 114():e180405. PubMed ID: 30726344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan, ID Screen and Leishmania 96), a rapid test (Speed Leish K) and an in-house IFAT.
    Solano-Gallego L; Villanueva-Saz S; Carbonell M; Trotta M; Furlanello T; Natale A
    Parasit Vectors; 2014 Mar; 7():111. PubMed ID: 24655335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
    Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
    Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of Escherichia coli total antigens as a complementary approach to address seropositivity to Leishmania antigens in canine leishmaniosis.
    Lima C; Mesquita JR; Brancal H; Vahlenkamp T; Teixeira AR; Cardoso L; Amorim C; Santarém N; DA Silva AC
    Parasitology; 2017 Sep; 144(10):1384-1393. PubMed ID: 28534448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a recombinant protein for the serological diagnosis of canine leishmaniasis.
    Boarino A; Bollo E; Prunotto L; Canale L; Uslenghi F; Poletti P
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):527-36. PubMed ID: 18262268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three recombinant Leishmania infantum antigens in human and canine visceral leishmaniasis diagnosis.
    Fonseca AM; Faria AR; Rodrigues FT; Nagem RA; Magalhães RD; Cunha JL; Bartholomeu DC; de Andrade HM
    Acta Trop; 2014 Sep; 137():25-30. PubMed ID: 24801885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection.
    Fujimori M; de Almeida ADBPF; Barrouin-Melo SM; Cortez LRPB; Duthie MS; Hiramoto RM; de Pinho FA; Reed SG; Sousa VRF; Souza NF; Soares RM; Tolezano JE; Sanchez MCA; Goto H
    Mem Inst Oswaldo Cruz; 2021; 116():e200428. PubMed ID: 33729396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine visceral leishmaniasis follow-up: a new anti-IgG serological test more sensitive than ITS-1 conventional PCR.
    Faria AR; Pires SDF; Reis AB; Coura-Vital W; Silveira JAGD; Sousa GM; Bueno MLC; Gazzinelli RT; Andrade HM
    Vet Parasitol; 2017 Dec; 248():62-67. PubMed ID: 29173543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
    Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Ludolf F; Steiner BT; Reis TAR; Santos TTO; Costa LE; Martins VT; Galvani NC; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Duarte MC; Menezes-Souza D; Silveira JAG; Moreira RLF; Machado-de-Ávila RA; Tupinambás U; Gonçalves DU; Coelho EAF
    Immunol Lett; 2020 Apr; 220():11-20. PubMed ID: 31981576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection and persistent positivity of anti-Leishmania antibodies using a recombinant protein-based ELISA in naturally infected dogs in Brazil.
    de Jesus MS; Cruz JVA; Coelho LB; Borja LS; da Silva ED; Solcà MDS; Brodskyn CI; Fraga DBM
    Parasit Vectors; 2021 Aug; 14(1):398. PubMed ID: 34384487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
    Santos TTO; Cardoso MS; Machado AS; Siqueira WF; Ramos FF; Oliveira-da-Silva JA; Tavares GSV; Lage DP; Costa LE; de Freitas CS; Martins VT; Bandeira RS; Chávez-Fumagalli MA; Lyon S; Moreira RLF; de Magalhães-Soares DF; Silveira JAG; Tupinambás U; Caligiorne RB; Chaves AT; Rocha MOC; Fujiwara RT; Coelho EAF
    Microb Pathog; 2019 Dec; 137():103783. PubMed ID: 31600536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs.
    Porrozzi R; Santos da Costa MV; Teva A; Falqueto A; Ferreira AL; dos Santos CD; Fernandes AP; Gazzinelli RT; Campos-Neto A; Grimaldi G
    Clin Vaccine Immunol; 2007 May; 14(5):544-8. PubMed ID: 17314229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against Leishmania cross-react with Crithidia luciliae: indirect immunofluorescence and Dot-ELISA study in dogs.
    Martinkovic F; Marinculic A
    Parasitol Res; 2006 Mar; 98(4):378-80. PubMed ID: 16362336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Performance of ELISA test using recombinant rLiNTPDase2 from Leishmania infantum: a Phase II diagnosis of Canine Visceral Leishmaniasis.
    de Souza ACA; Castro RB; Dos Santos YL; Pavione NDRT; Agripino JM; Bahia MT; Machado-Coelho GLL; de Souza RF; de Oliveira LL; Souza CDSF; Bressan GC; Vasconcellos RS; de Almeida MR; Fietto JLR
    Acta Trop; 2020 Sep; 209():105535. PubMed ID: 32450137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.